Genetic testing for advanced cancers
Part of Cancer, Genetic & congenital clinical trials.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these cancer types: breast (specific type), lung, ovary, pancreas, prostate, colorectal, melanoma, GIST, thyroid, endometrial, or cholangiocarcinoma.
- If you have breast cancer, it must have spread and not responded to hormone therapy.
- For lung, pancreatic, colorectal, or prostate cancer, the disease must have spread to other parts of the body (metastatic).
- For ovarian cancer, it cannot be the mucinous or borderline type.
- For melanoma, you must have stage 4 or stage 3 that is being removed with surgery.
- For GIST, you need tumor testing for specific genetic changes if it has spread or if you are having surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study tests if early genetic testing of your tumor can help find targeted treatments for advanced cancers that are hard to treat, such as pancreatic, liver, or triple-negative breast cancer. It aims to match you with a therapy based on your tumor's genetic profile.
This trial is testing whether a new system that connects genetic test results to your medical records can help reduce healthcare gaps for people with advanced cancer. It may help your doctor better personalize your treatment.
This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.
Hear when a new Genetic Predisposition to Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.